Tolera Therapeutics is a Kalamazoo, Michigan based biotechnology company focusing on commercializing its therapeutic monoclonal antibody technology for the transplantation market. Building upon research done at the University of Kentucky and the Cleveland Clinic, Tolera Therapeutics is developing and commercializing therapies for immune modulation with the goal of addressing unmet medical needs with safer, more targeted solutions to reduce the risk of serious and toxic side effects often associated with immunotherapy.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/17/12 | $5,500,000 | Series B-3 |
SWMF Life Science Fund Triathlon Medical Ventures | undisclosed |
